WJCD  Vol.5 No.6 , June 2015
The Research of Treg Cells: Progress and Challenge
Author(s) Jinguo Zhu1,2*
ABSTRACT
T regulatory cells (Tregs) play an important role in the induction and maintenance of immunological tolerance to self and alloantigens. Recent findings in experimental transplant models have demonstrated that Treg could control and delay allograft rejection. Induction of immune tolerance decreases the risk of acute and chronic graft rejection after solid organ transplantation and can improve transplanted organ survival. Tregs are being tested in trials as a potential therapy in cell and solid organ transplantation. However, as we know, regulatory T cells (Tregs) are crucial for peripheral tolerance and are intimately involved in cancer. The influence of Tregs on cancer progression has been demonstrated in a large number of preclinical models and confirmed in several types of malignancies. Neoplastic processes trigger an increase of Treg numbers in draining lymph nodes, spleen, blood, and tumors, leading to the suppression of anti-tumor responses. In this review, we summarize some of the critical aspects of the immunoregulatory function of Treg cells in cancer and transplantation and discuss their potential research progress and challenge.

Cite this paper
Zhu, J. (2015) The Research of Treg Cells: Progress and Challenge. World Journal of Cardiovascular Diseases, 5, 150-165. doi: 10.4236/wjcd.2015.56018.
References
[1]   Hsieh, C.S., Lee, H.M. and Lio, C.W. (2012) Selection of Regulatory T Cells in the Thymus. Nature Reviews Immunology, 12, 157-167.
http://dx.doi.org/10.1038/nri3155

[2]   Sakaguchi, S. (2011) Regulatory T Cells: History and Perspective. Methods in Molecular Biology, 707, 3-17.
http://dx.doi.org/10.1007/978-1-61737-979-6_1

[3]   Hippen, K.L., Merkel, S.C., Schirm, D.K., et al. (2011) Generation and Large-Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft-versus-Host Disease. American Journal of Transplantation, 11, 1148-1157.
http://dx.doi.org/10.1111/j.1600-6143.2011.03558.x

[4]   Khan, M.A. and Nicolls, M.R. (2013) Complement-Mediated Microvascular Injury Leads to Chronic Rejection. Ad- vances in Experimental Medicine and Biology, 734, 233-246.
http://dx.doi.org/10.1007/978-1-4614-4118-2_16

[5]   Griesemer, A.D., Sorenson, E.C. and Hardy, M.A. (2010) The Role of the Thymus in Tolerance. Transplantation, 90, 465-474.
http://dx.doi.org/10.1097/TP.0b013e3181e7e54f

[6]   Hori, S., Nomura, T. and Sakaguchi, S. (2003) Control of Regulatory T Cell Development by the Transcription Factor Foxp3. Science, 299, 1057-1061.
http://dx.doi.org/10.1126/science.1079490

[7]   Issa, F. and Wood, K.J. (2010) CD4+ Regulatory T Cells in Solid Organ Transplantation. Current Opinion in Organ Transplantation, 15, 757-764.
http://dx.doi.org/10.1097/MOT.0b013e32834017ae

[8]   Schmetterer, K.G., Neunkirchner, A. and Pickl, W.F. (2012) Naturally Occurring Regulatory T Cells: Markers, Mechanisms, and Manipulation. The FASEB Journal, 26, 2253-2276.
http://dx.doi.org/10.1096/fj.11-193672

[9]   Baecher-Allan, C., Wolf, E. and Hafler, D.A. (2005) Functional Analysis of Highly Defined, FACS-Isolated Populations of Human Regulatory CD4+CD25+ T Cells. Clinical Immunology, 115, 10-18.
http://dx.doi.org/10.1016/j.clim.2005.02.018

[10]   Salomon, B. and Bluestone, J.A. (2001) Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmu- nity and Transplantation. Annual Review of Immunology, 19, 225-252.
http://dx.doi.org/10.1146/annurev.immunol.19.1.225

[11]   Soligo, M., Camperio, C., Caristi, S., et al. (2011) CD28 Costimulation Regulates FOXP3 in a RelA/NF-κB-Dependent Mechanism. European Journal of Immunology, 41, 503-513.
http://dx.doi.org/10.1002/eji.201040712

[12]   Josefowicz, S.Z., Lu, L.F. and Rudensky, A.Y. (2012) Regulatory T Cells: Mechanisms of Differentiation and Function. Annual Review of Immunology, 30, 531-564.
http://dx.doi.org/10.1146/annurev.immunol.25.022106.141623

[13]   Josefowicz, S.Z., Niec, R.E., Kim, H.Y., et al (2012). Extrathymically Generated Regulatory T Cells Control Mucosal TH2 Inflammation. Nature, 482, 395-399.
http://dx.doi.org/10.1038/nature10772

[14]   Samstein, R.M., Arvey, A., Josefowicz, S.Z., et al. (2012) Foxp3 Exploits a Pre-Existent Enhancer Landscape for Regulatory T Cell Lineage Specification. Cell, 151, 153-166.
http://dx.doi.org/10.1016/j.cell.2012.06.053

[15]   Greaves, P., Clear, A., Coutinho, R., et al. (2013) Expression of FOXP3, CD68, and CD20 at Diagnosis in the Micro-environment of Classical Hodgkin Lymphoma Is Predictive of Outcome. Journal of Clinical Oncology, 31, 256-262.
http://dx.doi.org/10.1200/JCO.2011.39.9881

[16]   Bilate, A.M. and Lafaille, J.J. (2012) Induced CD4+Foxp3+ Regulatory T Cells in Immune Tolerance. Annual Review of Immunology, 30, 733-758.
http://dx.doi.org/10.1146/annurev-immunol-020711-075043

[17]   Nankivell, B.J. and Alexander, S.I. (2010) Rejection of the Kidney Allograft. The New England Journal of Medicine, 363, 1451-1462.
http://dx.doi.org/10.1056/NEJMra0902927

[18]   Bohmig, G.A., Wahrmann, M. and Saemann, M.D. (2010) Detecting Adaptive Immunity: Applications in Transplantation Monitoring. Molecular Diagnosis & Therapy, 14, 1-11.
http://dx.doi.org/10.1007/BF03256348

[19]   Sandrin, M.S. (2009) Transplantation Immunobiology: Two Important Themes. Immunology & Cell Biology, 87, 194.
http://dx.doi.org/10.1038/icb.2009.6

[20]   Fandrich, F. (2011) Tolerance in Clinical Transplantation: Progress, Challenge or Just a Dream? Langenbeck’s Ar- chives of Surgery, 396, 475-487.
http://dx.doi.org/10.1007/s00423-011-0757-z

[21]   Hernandez-Fuentes, M.P. and Lechler, R.I. (2010) A “Biomarker Signature” for Tolerance in Transplantation. Nature Reviews Nephrology, 6, 606-613.
http://dx.doi.org/10.1038/nrneph.2010.112

[22]   Moore, R., Ravindran, V. and Baboolal, K. (2006) The Burden of New-Onset Diabetes Mellitus after Transplantation. Clinical Transplantation, 20, 755-761.
http://dx.doi.org/10.1111/j.1399-0012.2006.00565.x

[23]   Wadei, H.M. and Textor, S.C. (2010) Hypertension in the Kidney Transplant Recipient. Transplantation Reviews (Orlando), 24, 105-120.
http://dx.doi.org/10.1016/j.trre.2010.02.001

[24]   Onishi, H., Morisaki, T. and Katano, M. (2012) Immunotherapy Approaches Targeting Regulatory T-Cells. Anticancer Research, 32, 997-1003.

[25]   Bluestone, J.A., Liu, W., Yabu, J.M., et al. (2008) The Effect of Costimulatory and Interleukin 2 Receptor Blockade on Regulatory T Cells in Renal Transplantation. American Journal of Transplantation, 8, 2086-2096.
http://dx.doi.org/10.1111/j.1600-6143.2008.02377.x

[26]   de Rezende, L.C., Silva, I.V., Rangel, L.B. and Guimaraes, M.C. (2010) Regulatory T Cell as a Target for Cancer Therapy. Archivum Immunologiae et Therapia Experimentalis (Warsz), 58, 179-190.
http://dx.doi.org/10.1007/s00005-010-0075-0

[27]   Kawai, M., Kitade, H., Mathieu, C., et al. (2005) Inhibitory and Stimulatory Effects of Cyclosporine A on the Development of Regulatory T Cells in Vivo. Transplantation, 79, 1073-1077.
http://dx.doi.org/10.1097/01.TP.0000153505.73700.32

[28]   Demirkiran, A., Sewgobind, V.D., van der Weijde, J., et al. (2009) Conversion from Calcineurin Inhibitor to Myco-phenolate Mofetil-Based Immunosuppression Changes the Frequency and Phenotype of CD4+FOXP3+ Regulatory T Cells. Transplantation, 87, 1062-1068.
http://dx.doi.org/10.1097/tp.0b013e31819d2032

[29]   Zhang, Z.X., Yang, L., Young, K.J., DuTemple, B. and Zhang, L. (2000) Identification of a Previously Unknown Antigen-Specific Regulatory T Cell and Its Mechanism of Suppression. Nature Medicine, 6, 782-789.
http://dx.doi.org/10.1038/77513

[30]   Monteiro, M., Almeida, C.F., Caridade, M., et al. (2010) Identification of Regulatory Foxp3+ Invariant NKT Cells Induced by TGF-Beta. The Journal of Immunology, 185, 2157-2163.
http://dx.doi.org/10.4049/jimmunol.1000359

[31]   Curiel, T.J., Coukos, G., Zou, L., et al. (2004) Specific Recruitment of Regulatory T Cells in Ovarian Carcinoma Fosters Immune Privilege and Predicts Reduced Survival. Nature Medicine, 10, 942-949.
http://dx.doi.org/10.1038/nm1093

[32]   Miyara, M. and Sakaguchi, S. (2011) Human FoxP3+CD4+ Regulatory T Cells: Their Knowns and Unknowns. Immunology and Cell Biology, 89, 346-351.
http://dx.doi.org/10.1038/icb.2010.137

[33]   Collison, L.W., Workman, C.J., Kuo, T.T., et al. (2007) The Inhibitory Cytokine IL-35 Contributes to Regulatory T-Cell Function. Nature, 450, 566-569.
http://dx.doi.org/10.1038/nature06306

[34]   Fassbender, M., Gerlitzki, B., Ullrich, N., et al. (2010) Cyclic Adenosine Monophosphate and IL-10 Coordinately Contribute to nTreg Cell-Mediated Suppression of Dendritic Cell Activation. Cellular Immunology, 265, 91-96.
http://dx.doi.org/10.1016/j.cellimm.2010.07.007

[35]   Tsang, J.Y., Tanriver, Y., Jiang, S., et al. (2009) Indefinite Mouse Heart Allograft Survival in Recipient Treated with CD4+CD25+ Regulatory T Cells with Indirect Allospecificity and Short Term Immunosuppression. Transplant Immunology, 21, 203-209.
http://dx.doi.org/10.1016/j.trim.2009.05.003

[36]   Golshayan, D., Jiang, S., Tsang, J., Garin, M.I., Mottet, C. and Lechler, R.I. (2007) In Vitro-Expanded Donor Alloantigen-Specific CD4+CD25+ Regulatory T Cells Promote Experimental Transplantation Tolerance. Blood, 109, 827-835.
http://dx.doi.org/10.1182/blood-2006-05-025460

[37]   Joffre, O., Santolaria, T., Calise, D., et al. (2008) Prevention of Acute and Chronic Allograft Rejection with CD4+ CD25+Foxp3+ Regulatory T Lymphocytes. Nature Medicine, 14, 88-92.
http://dx.doi.org/10.1038/nm1688

[38]   Cao, T., Soto, A., Zhou, W., et al. (2009) Ex Vivo Expanded Human CD4+CD25+Foxp3+ Regulatory T Cells Prevent Lethal Xenogenic Graft versus Host Disease (GVHD). Cellular Immunology, 258, 65-71.
http://dx.doi.org/10.1016/j.cellimm.2009.03.013

[39]   Shalev, I., Schmelzle, M., Robson, S.C. and Levy, G. (2011) Making Sense of Regulatory T Cell Suppressive Function. Seminars in Immunology, 23, 282-292.
http://dx.doi.org/10.1016/j.smim.2011.04.003

[40]   Nadig, S.N., Wieckiewicz, J., Wu, D.C., et al. (2010) In Vivo Prevention of Transplant Arteriosclerosis by ex Vivo-Expanded Human Regulatory T Cells. Nature Medicine, 16, 809-813.
http://dx.doi.org/10.1038/nm.2154

[41]   Issa, F., Hester, J., Goto, R., Nadig, S.N., Goodacre, T.E. and Wood, K. (2010) Ex Vivo-Expanded Human Regulatory T Cells Prevent the Rejection of Skin Allografts in a Humanized Mouse Model. Transplantation, 90, 1321-1327.
http://dx.doi.org/10.1097/TP.0b013e3181ff8772

[42]   Tran, D.Q., Andersson, J., Hardwick, D., Bebris, L., Illei, G.G. and Shevach, E.M. (2009) Selective Expression of Latency-Associated Peptide (LAP) and IL-1 Receptor Type I/II (CD121a/CD121b) on Activated Human FOXP3+ Regulatory T Cells Allows for Their Purification from Expansion Cultures. Blood, 113, 5125-5133.
http://dx.doi.org/10.1182/blood-2009-01-199950

[43]   Ukena, S.N., Hopting, M., Velaga, S., et al. (2011) Isolation Strategies of Regulatory T Cells for Clinical Trials: Phenotype, Function, Stability, and Expansion Capacity. Experimental Hematology, 39, 1152-1160.
http://dx.doi.org/10.1016/j.exphem.2011.08.010

[44]   Marek, N., Bieniaszewska, M., Krzystyniak, A., et al. (2011) The Time Is Crucial for ex Vivo Expansion of T Regulatory Cells for Therapy. Cell Transplantation, 20, 1747-1758.
http://dx.doi.org/10.3727/096368911X566217

[45]   Tresoldi, E., Dell’Albani, I., Stabilini, A., et al. (2011) Stability of Human Rapamycin-Expanded CD4+CD25+ T Regu- latory Cells. Haematologica, 96, 1357-1365.
http://dx.doi.org/10.3324/haematol.2011.041483

[46]   Gurkan, S., Luan, Y., Dhillon, N., et al. (2010) Immune Reconstitution Following Rabbit Antithymocyte Globulin. American Journal of Transplantation, 10, 2132-2141.
http://dx.doi.org/10.1111/j.1600-6143.2010.03210.x

[47]   Sojka, D.K., Huang, Y.-H. and Fowell, D.J. (2008) Mechanisms of Regulatory T-Cell Suppression—A Diverse Arsenal for a Moving Target. Immunology, 124, 13-22.
http://dx.doi.org/10.1111/j.1365-2567.2008.02813.x

[48]   Lim, H.W., Hillsamer, P., Banham, A.H. and Kim, C.H. (2005) Cutting Edge: Direct Suppression of B Cells by CD4+ CD25+ Regulatory T Cells. The Journal of Immunology, 175, 4180-4183.
http://dx.doi.org/10.4049/jimmunol.175.7.4180

[49]   Fan, Z., Spencer, J.A., Lu, Y., et al. (2010) In Vivo Tracking of “Color-Coded” Effector, Natural and Induced Regulatory T Cells in the Allograft Response. Nature Medicine, 16, 718-722.
http://dx.doi.org/10.1038/nm.2155

[50]   Tsang, J.Y., Ratnasothy, K., Li, D., et al. (2011) The Potency of Allospecific Tregs Cells Appears to Correlate with T Cell Receptor Functional Avidity. American Journal of Transplantation, 11, 1610-1620.
http://dx.doi.org/10.1111/j.1600-6143.2011.03650.x

[51]   Feng, G., Nadig, S.N., Backdahl, L., et al. (2011) Functional Regulatory T Cells Produced by Inhibiting Cyclic Nucleotide Phosphodiesterase Type 3 Prevent Allograft Rejection. Science Translational Medicine, 3, 83ra40.
http://dx.doi.org/10.1126/scitranslmed.3002099

[52]   Ding, Y., Xu, J. and Bromberg, J.S. (2012) Regulatory T Cell Migration during an Immune Response. Trends in Immunology, 33, 174-180.
http://dx.doi.org/10.1016/j.it.2012.01.002

[53]   Duhen, T., Duhen, R., Lanzavecchia, A., Sallusto, F. and Campbell, D.J. (2012) Functionally Distinct Subsets of Human FOXP3+ Treg Cells That Phenotypically Mirror Effector Th Cells. Blood, 119, 4430-4440.
http://dx.doi.org/10.1182/blood-2011-11-392324

[54]   Sagoo, P., Perucha, E., Sawitzki, B., et al. (2010) Development of a Cross-Platform Biomarker Signature to Detect Renal Transplant Tolerance in Humans. Journal of Clinical Investigation, 120, 1848-1861.
http://dx.doi.org/10.1172/JCI39922

[55]   Di Ianni, M., Falzetti, F., Carotti, A., et al. (2011) Tregs Prevent GVHD and Promote Immune Reconstitution in HLA-Haploidentical Transplantation. Blood, 117, 3921-3928.
http://dx.doi.org/10.1182/blood-2010-10-311894

[56]   Kimura, A. and Kishimoto, T. (2010) IL-6: Regulator of Treg/Th17 Balance. European Journal of Immunology, 40, 1830-1835.
http://dx.doi.org/10.1002/eji.201040391

[57]   Fujimoto, M., Nakano, M., Terabe, F., et al. (2011) The Influence of Excessive IL-6 Production in Vivo on the Development and Function of Foxp3+ Regulatory T Cells. The Journal of Immunology, 186, 32-40.
http://dx.doi.org/10.4049/jimmunol.0903314

[58]   Kim, J., Sonawane, S., Lee, M.K., et al. (2010) Blockade of GITR-GITRL Interaction Maintains Regulatory T Cell Function to Prolong Allograft Survival. European Journal of Immunology, 40, 1369-1374.
http://dx.doi.org/10.1002/eji.200940046

[59]   Quigley, M.F. (2010) Convergent Recombination Shapes the Clonotypic Landscape of the Naive T-Cell Repertoire. Proceedings of the National Academy of Sciences of the United States of America, 107, 19414-19419.
http://dx.doi.org/10.1073/pnas.1010586107

[60]   Thomas, P.G., Handel, A., Doherty, P.C., et al. (2013) Ecological Analysis of Antigen-Specific CTL Repertoires Defines the Relationship between Naive and Immune T-Cell Populations. Proceedings of the National Academy of Sciences of the United States of America, 110, 1839-1844.
http://dx.doi.org/10.1073/pnas.1222149110

[61]   Guillonneau, C., Picarda, E. and Anegon, I. (2010) CD8+ Regulatory T Cells in Solid Organ Transplantation. Current Opinion in Organ Transplantation, 15, 751-756.
http://dx.doi.org/10.1097/MOT.0b013e32834016d1

[62]   Li, X.L., et al. (2010) Mechanism and Localization of CD8 Regulatory T Cells in a Heart Transplant Model of Tolerance. The Journal of Immunology, 185, 823-833.
http://dx.doi.org/10.4049/jimmunol.1000120

[63]   Picarda, E., Anegon, I. and Guillonneau, C. (2011) T-Cell Receptor Specificity of CD8+ Tregs in Allotransplantation. Immunotherapy, 3, 35-37.
http://dx.doi.org/10.2217/imt.11.37

[64]   Sagoo, P., Ali, N., Garg, G., et al. (2011) Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells. Science Translational Medicine, 3, 83-92.
http://dx.doi.org/10.1126/scitranslmed.3002076

[65]   Pasquet, L., Joffre, O., Santolaria, T., et al. (2011) Hematopoietic Chimerism and Transplantation Tolerance: A Role for Regulatory T Cells. Frontiers in Immunology, 2, 80.
http://dx.doi.org/10.3389/fimmu.2011.00080

[66]   Ohkura, N. and Sakaguchi, S. (2010) Regulatory T Cells: Roles of T Cell Receptor for Their Development and Function. Seminars in Immunopathology, 32, 95-106.
http://dx.doi.org/10.1007/s00281-010-0200-5

[67]   Fohse, L. (2011) High TCR Diversity Ensures Optimal Function and Homeostasis of Foxp3+ Regulatory T Cells. European Journal of Immunology, 41, 3101-3113.
http://dx.doi.org/10.1002/eji.201141986

[68]   Wood, K.J., Bushell, A. and Hester, J. (2012) Regulatory Immune Cells in Transplantation. Nature Reviews Immuno- logy, 12, 417-430.
http://dx.doi.org/10.1038/nri3227

[69]   Liu, Y.C. (2012) The Energetic Basis Underpinning T-Cell Receptor Recognition of a Super-Bulged Peptide Bound to a Major Histo-compatibility Complex Class I Molecule. The Journal of Biological Chemistry, 287, 12267-12276.
http://dx.doi.org/10.1074/jbc.M112.344689

[70]   Ekeruche-Makinde, J. (2013) Peptide Length Determines the Outcome of TCR/Peptide-MHCI Engagement. Blood, 121, 1112-1123.
http://dx.doi.org/10.1182/blood-2012-06-437202

[71]   Leavenworth, J.W., Tang, X., Kim, H.J., et al. (2013) Amelioration of Arthritis through Mobilization of Peptide-Specific CD8+ Regulatory T Cells. Journal of Clinical Investigation, 123, 1382-1389.
http://dx.doi.org/10.1172/JCI66938

[72]   Muller, Y.D., Seebach, J.D., Bühler, L.H., et al. (2011) Trans-plantation Tolerance: Clinical Potential of Regulatory T Cells. Self/Nonself, 2, 26-34.
http://dx.doi.org/10.4161/self.2.1.15422

[73]   Pilat, N., Farkas, A.M., et al. (2014) T-Regulatory Cell Treatment Prevents Chronic Rejection of Heart Allografts in a Murine Mixed Chimerism Model. The Journal of Heart and Lung Transplantation, 33, 429-437.
http://dx.doi.org/10.1016/j.healun.2013.11.004

[74]   Darrasse-Jèze, G. and Podsypanina, K. (2013) How Numbers, Nature, and Immune Status of Foxp3+ Regulatory T- Cells Shape the Early Immunological Events in Tumor Development. Frontiers in Immunology, 4, 292.
http://dx.doi.org/10.3389/fimmu.2013.00292

[75]   Hollenbeak, C.S., Todd, M.M., Billingsley, E.M., et al. (2005) Increased Incidence of Melanoma in Renal Transplantation Recipients. Cancer, 104, 1962-1710.
http://dx.doi.org/10.1002/cncr.21404

[76]   Zhang, L., Conejo-Garcia, J.R., Katsaros, D., et al. (2003) Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer. The New England Journal of Medicine, 348, 203-213.
http://dx.doi.org/10.1056/NEJMoa020177

[77]   Liyanage, U.K., Moore, T.T., Joo, H.G., et al. (2002) Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma. The Journal of Immunology, 169, 2756-2761.
http://dx.doi.org/10.4049/jimmunol.169.5.2756

[78]   deLeeuw, R.J., Kost, S.E., Kakal, J.A., et al. (2012) The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature. Clinical Cancer Research, 102, 345-352.
http://dx.doi.org/10.1158/1078-0432.ccr-11-3216

[79]   Martin, F., Ladoire, S., Mignot, G., et al. (2010) Human FOXP3 and Cancer. Oncogene, 29, 4121-4129.
http://dx.doi.org/10.1038/onc.2010.174

[80]   Tanchot, C., Terme, M., Pere, H., et al. (2012) Tumor-Infiltrating Regulatory T Cells: Phenotype, Role, Mechanism of Expansion in Situ and Clinical Significance. Cancer Microenvironment, 6, 147-157.
http://dx.doi.org/10.1007/s12307-012-0122-y

[81]   Ladoire, S., Martin, F. and Ghiringhelli, F. (2011) Prognostic Role of FOXP3+ Regulatory T Cells Infiltrating Human Carcinomas: The Paradox of Colorectal Cancer. Cancer Immunology, Immunotherapy, 60, 909-918.
http://dx.doi.org/10.1007/s00262-011-1046-y

[82]   Ghoreschi, K., Laurence, A., Yang, X.P., et al. (2010) Generation of Pathogenic TH17 Cells in the Absence of TGF-Beta Signalling. Nature, 467, 967-971.
http://dx.doi.org/10.1038/nature09447

[83]   Baratelli, F., Lee, J.M., Hazra, S., et al. (2010) PGE(2) Contributes to TGF-Beta Induced T Regulatory Cell Function in Human Non-Small Cell Lung Cancer. American Journal of Translational Research, 2, 356-367.

[84]   Willimsky, G. and Blankenstein, T. (2005) Sporadic Immunogenic Tumours Avoid Destruction by Inducing T-Cell Tolerance. Nature, 437, 141-146.
http://dx.doi.org/10.1038/nature03954

[85]   Savage, P.A., Malchow, S. and Leventhal, D.S. (2013) Basic Principles of Tumor-Associated Regulatory T Cell Bio- logy. Trends in Immunology, 34, 33-40.
http://dx.doi.org/10.1016/j.it.2012.08.005

[86]   Fontenot, J.D., Rasmussen, J.P., Williams, L.M., et al. (2005) Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3. Immunity, 22, 329-341.
http://dx.doi.org/10.1016/j.immuni.2005.01.016

[87]   Getnet, D., Grosso, J.F., Goldberg, M.V., et al. (2010) A Role for the Transcription Factor Helios in Human CD4+ CD25+ Regulatory T Cells. Molecular Immunology, 47, 1595-1600.
http://dx.doi.org/10.1016/j.molimm.2010.02.001

[88]   Thornton, A.M., Korty, P.E., Tran, D.Q., et al. (2010) Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells. The Journal of Immunology, 184, 3433-3441.
http://dx.doi.org/10.4049/jimmunol.0904028

[89]   Malchow, S., Leventhal, D.S., Nishi, S., et al. (2013) Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells. Science, 339, 1219-1224.
http://dx.doi.org/10.1126/science.1233913

[90]   Paiva, R.S., Lino, A.C., Bergman, M.L., et al. (2013) Recent Thymic Emigrants Are the Preferential Precursors of Regulatory T Cells Differentiated in the Periphery. Proceedings of the National Academy of Sciences of the United States of America, 110, 6494-6499.
http://dx.doi.org/10.1073/pnas.1221955110

[91]   Vence, L., Palucka, A.K., Fay, J.W., et al. (2007) Circulating Tumor Antigen-Specific Regulatory T Cells in Patients with Metastatic Melanoma. Proceedings of the National Academy of Sciences of the United States of America, 104, 20884-20889.
http://dx.doi.org/10.1073/pnas.0710557105

[92]   Szajnik, M., Czystowska, M., Szczepanski, M.J., et al. (2010) Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg). PLoS ONE, 5, e11469.
http://dx.doi.org/10.1371/journal.pone.0011469

[93]   Wehrens, E.J., Mijnheer, G., Duurland, C.L., et al. (2011) Functional Human Regulatory T Cells Fail to Control Autoimmune Inflammation Due to PKB/c-akt Hyperactivation in Effector Cells. Blood, 118, 3538-3548.
http://dx.doi.org/10.1182/blood-2010-12-328187

[94]   Quintana, F.J., Iglesias, A.H., Farez, M.F., et al. (2010) Adaptive Autoimmunity and Foxp3-Based Immunoregulation in Zebrafish. PLoS ONE, 5, e9478.
http://dx.doi.org/10.1371/journal.pone.0009478

[95]   Samstein, R.M., Josefowicz, S.Z., Arvey, A., et al. (2012) Extrathymic Generation of Regulatory T Cells in Placental Mammals Mitigates Maternal-Fetal Conflict. Cell, 150, 29-38.

[96]   Maury, S., Lemoine, F.M., Hicheri, Y., et al. (2010) CD4+CD25+ Regulatory T Cell Depletion Improves the Graft- versus-Tumor Effect of Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation. Science Translational Medicine, 2, 41-52.

[97]   Dons, E.M., Raimondi, G., Cooper, D.K.C., et al. (2010) Non-Human Primate Regulatory T Cells: Current Biology and Implications for Transplantation. Transplantation, 90, 811-816.
http://dx.doi.org/10.1097/TP.0b013e3181ebf782

[98]   Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674.
http://dx.doi.org/10.1016/j.cell.2011.02.013

[99]   Koebel, C.M., Vermi, W., Swann, J.B., et al. (2007) Adaptive Immunity Maintains Occult Cancer in an Equilibrium State. Nature, 450, 903-924.
http://dx.doi.org/10.1038/nature06309

[100]   Menetrier-Caux, C., Curiel, T., Faget, J., et al. (2012) Targeting Regulatory T Cells. Targeted Oncology, 7, 15-28.
http://dx.doi.org/10.1007/s11523-012-0208-y

[101]   Yamaguchi, T., Wing, J.B. and Sakaguchi, S. (2011) Two Modes of Immune Suppression by Foxp3+ Regulatory T Cells under Inflammatory or Non-Inflammatory Conditions. Seminars in Immunology, 23, 424-430.
http://dx.doi.org/10.1016/j.smim.2011.10.002

[102]   Miyao, T., Floess, S., Setoguchi, R., et al. (2012) Plasticity of Foxp3(+) T Cells Reflects Promiscuous Foxp3 Expression in Conventional T Cells but Not Reprogramming of Regulatory T Cells. Immunity, 36, 262-275.
http://dx.doi.org/10.1016/j.immuni.2011.12.012

[103]   Elkord, E., Sharma, S., Burt, D.J. and Hawkins, R.E. (2011) Expanded Subpopulation of FoxP3+ T Regulatory Cells in Renal Cell Carcinoma Co-Express Helios, Indicating They Could Be Derived from Natural but Not Induced Tregs. Clinical Immunology, 140, 218-222.
http://dx.doi.org/10.1016/j.clim.2011.04.014

 
 
Top